{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:16:34Z","timestamp":1778022994669,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Therapeutic approaches to combat type 1 diabetes (T1D) include donor pancreas transplantation, exogenous insulin administration and immunosuppressive therapies. However, these clinical applications are limited due to insufficient tissue compatible donors, side effects of exogenous insulin administration and\/or increased onset of opportunistic infections attributable\u00a0to induced global immunosuppression. An alternative approach to alleviate disease states is to utilize insulin-producing pancreatic islets seeded in a bioscaffold for implantation into diabetic recipients. The present studies now report that a newly developed cationic polymer biomaterial serves as an efficient bioscaffold for delivery of donor syngeneic pancreatic islet cells to reverse hyperglycemia in murine streptozotocin induced- or non-obese diabetic mouse models of T1D. Intraperitoneal implantation of pancreatic islets seeded within the copolymer bioscaffold supports long-term cell viability, response to extracellular signaling cues and ability to produce soluble factors into the microenvironment. Elevated insulin levels were measured in recipient diabetic mice upon implantation of the islet-seeded biomaterial coupled with reduced blood glucose levels, collectively resulting in increased survival and stabilization of metabolic indices. Importantly, the implanted islet-seeded biomaterial assembled into a solid organoid substructure that reorganized the extracellular matrix compartment and recruited endothelial progenitors for neovascularization. This allowed survival of the graft long-term<jats:italic>in vivo<\/jats:italic>and access to the blood for monitoring glucose levels. These results highlight the novelty, simplicity and effectiveness of this biomaterial for tissue regeneration and<jats:italic>in vivo<\/jats:italic>restoration of organ functions.<\/jats:p>","DOI":"10.1038\/s41598-020-60947-x","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T11:02:46Z","timestamp":1583751766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pancreatic islets seeded in a novel bioscaffold forms an organoid to rescue insulin production and reverse hyperglycemia in models of type 1 diabetes"],"prefix":"10.1038","volume":"10","author":[{"given":"Diana M.","family":"Elizondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nailah Z. D.","family":"Brandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo L. L.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana R.","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamel","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Lipscomb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"60947_CR1","doi-asserted-by":"crossref","unstructured":"Atkinson, M.A. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harbor perspectives in medicine 2(2012).","DOI":"10.1101\/cshperspect.a007641"},{"key":"60947_CR2","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/0140-6736(93)90947-F","volume":"341","author":"M Lowdell","year":"1993","unstructured":"Lowdell, M. & Bottazzo, G. F. Autoimmunity and insulin-dependent diabetes. Lancet 341, 1378\u20131379 (1993).","journal-title":"Lancet"},{"key":"60947_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/978-90-481-3271-3_24","volume":"654","author":"D La Torre","year":"2010","unstructured":"La Torre, D. & Lernmark, A. Immunology of beta-cell destruction. Advances in experimental medicine and biology 654, 537\u2013583 (2010).","journal-title":"Advances in experimental medicine and biology"},{"key":"60947_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/dme.12099","volume":"30","author":"S Eringsmark Regnell","year":"2013","unstructured":"Eringsmark Regnell, S. & Lernmark, A. The environment and the origins of islet autoimmunity and Type 1 diabetes. Diabetic medicine: a journal of the British Diabetic Association 30, 155\u2013160 (2013).","journal-title":"Diabetic medicine: a journal of the British Diabetic Association"},{"key":"60947_CR5","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc12-0063","volume":"35","author":"FB Barton","year":"2012","unstructured":"Barton, F. B. et al. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes care 35, 1436\u20131445 (2012).","journal-title":"Diabetes care"},{"key":"60947_CR6","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2337\/db15-1525","volume":"65","author":"DM Berman","year":"2016","unstructured":"Berman, D. M. et al. Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation Within a Biologic Resorbable Scaffold. Diabetes 65, 1350\u20131361 (2016).","journal-title":"Diabetes"},{"key":"60947_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/03009734000000059","volume":"105","author":"W Bennet","year":"2000","unstructured":"Bennet, W., Groth, C. G., Larsson, R., Nilsson, B. & Korsgren, O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Upsala journal of medical sciences 105, 125\u2013133 (2000).","journal-title":"Upsala journal of medical sciences"},{"key":"60947_CR8","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(02)12020-4","volume":"360","author":"L Moberg","year":"2002","unstructured":"Moberg, L. et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360, 2039\u20132045 (2002).","journal-title":"Lancet"},{"key":"60947_CR9","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2337\/diabetes.54.6.1755","volume":"54","author":"H Johansson","year":"2005","unstructured":"Johansson, H. et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 54, 1755\u20131762 (2005).","journal-title":"Diabetes"},{"key":"60947_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/01.tp.0000275401.80187.1e","volume":"84","author":"DM Berman","year":"2007","unstructured":"Berman, D. M. et al. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 84, 308\u2013315 (2007).","journal-title":"Transplantation"},{"key":"60947_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.phrs.2015.02.010","volume":"98","author":"N Fotino","year":"2015","unstructured":"Fotino, N., Fotino, C. & Pileggi, A. Re-engineering islet cell transplantation. Pharmacological research 98, 76\u201385 (2015).","journal-title":"Pharmacological research"},{"key":"60947_CR12","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2337\/db13-1039","volume":"62","author":"A Pileggi","year":"2013","unstructured":"Pileggi, A. & Ricordi, C. A new home for pancreatic islet transplants: the bone marrow. Diabetes 62, 3333\u20133335 (2013).","journal-title":"Diabetes"},{"key":"60947_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11892-011-0210-2","volume":"11","author":"DJ Borg","year":"2011","unstructured":"Borg, D. J. & Bonifacio, E. The use of biomaterials in islet transplantation. Current diabetes reports 11, 434\u2013444 (2011).","journal-title":"Current diabetes reports"},{"key":"60947_CR14","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2337\/db13-1742","volume":"63","author":"G Orlando","year":"2014","unstructured":"Orlando, G. et al. Cell replacement strategies aimed at reconstitution of the beta-cell compartment in type 1 diabetes. Diabetes 63, 1433\u20131444 (2014).","journal-title":"Diabetes"},{"key":"60947_CR15","doi-asserted-by":"publisher","first-page":"e0130169","DOI":"10.1371\/journal.pone.0130169","volume":"10","author":"U Johansson","year":"2015","unstructured":"Johansson, U. et al. Pancreatic Islet Survival and Engraftment Is Promoted by Culture on Functionalized Spider Silk Matrices. PloS one 10, e0130169 (2015).","journal-title":"PloS one"},{"key":"60947_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"AJ Vegas","year":"2016","unstructured":"Vegas, A. J. et al. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nature medicine 22, 306\u2013311 (2016).","journal-title":"Nature medicine"},{"key":"60947_CR17","doi-asserted-by":"publisher","first-page":"E263","DOI":"10.1073\/pnas.1708806115","volume":"115","author":"D An","year":"2018","unstructured":"An, D. et al. Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America 115, E263\u2013E272 (2018).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"60947_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(79)91008-0","volume":"1","author":"A Andersson","year":"1979","unstructured":"Andersson, A. Islet implantation normalises hyperglycaemia caused by streptozotocin-induced insulitis. Experiments in mice. Lancet 1, 581\u2013584 (1979).","journal-title":"Experiments in mice. Lancet"},{"key":"60947_CR19","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1016\/S0142-9612(03)00319-3","volume":"24","author":"D Kato","year":"2003","unstructured":"Kato, D. et al. The design of polymer microcarrier surfaces for enhanced cell growth. Biomaterials 24, 4253\u20134264 (2003).","journal-title":"Biomaterials"},{"key":"60947_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF00749935","volume":"13","author":"J Varani","year":"1993","unstructured":"Varani, J., Inman, D. R., Fligiel, S. E. & Hillegas, W. J. Use of recombinant and synthetic peptides as attachment factors for cells on microcarriers. Cytotechnology 13, 89\u201398 (1993).","journal-title":"Cytotechnology"},{"key":"60947_CR21","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1210\/en.2012-1257","volume":"153","author":"H Katsuta","year":"2012","unstructured":"Katsuta, H. et al. Subpopulations of GFP-marked mouse pancreatic beta-cells differ in size, granularity, and insulin secretion. Endocrinology 153, 5180\u20135187 (2012).","journal-title":"Endocrinology"},{"key":"60947_CR22","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2337\/db05-0615","volume":"55","author":"Y Qi","year":"2006","unstructured":"Qi, Y. et al. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55, 3083\u20133090 (2006).","journal-title":"Diabetes"},{"key":"60947_CR23","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1172\/JCI119865","volume":"100","author":"N Barzilai","year":"1997","unstructured":"Barzilai, N. et al. Leptin selectively decreases visceral adiposity and enhances insulin action. The Journal of clinical investigation 100, 3105\u20133110 (1997).","journal-title":"The Journal of clinical investigation"},{"key":"60947_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.yfrne.2003.10.001","volume":"24","author":"A Sahu","year":"2003","unstructured":"Sahu, A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Frontiers in neuroendocrinology 24, 225\u2013253 (2003).","journal-title":"Frontiers in neuroendocrinology"},{"key":"60947_CR25","doi-asserted-by":"publisher","first-page":"7625947","DOI":"10.1155\/2016\/7625947","volume":"2016","author":"TM Suszynski","year":"2016","unstructured":"Suszynski, T. M., Avgoustiniatos, E. S. & Papas, K. K. Oxygenation of the Intraportally Transplanted Pancreatic Islet. J. Diabetes Res. 2016, 7625947 (2016).","journal-title":"J. Diabetes Res."},{"key":"60947_CR26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.2337\/db10-0793","volume":"60","author":"EM Akirav","year":"2011","unstructured":"Akirav, E. M. et al. Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucose. Diabetes 60, 876\u2013883 (2011).","journal-title":"Diabetes"},{"key":"60947_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nature07445","volume":"456","author":"C Stockmann","year":"2008","unstructured":"Stockmann, C. et al. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456, 814\u2013818 (2008).","journal-title":"Nature"},{"key":"60947_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/jlb.55.3.410","volume":"55","author":"C Sunderkotter","year":"1994","unstructured":"Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. & Sorg, C. Macrophages and angiogenesis. Journal of leukocyte biology 55, 410\u2013422 (1994).","journal-title":"Journal of leukocyte biology"},{"key":"60947_CR29","first-page":"49","volume":"8","author":"Y Tochino","year":"1987","unstructured":"Tochino, Y. The NOD mouse as a model of type I diabetes. Critical reviews in immunology 8, 49\u201381 (1987).","journal-title":"Critical reviews in immunology"},{"key":"60947_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson, M. S. & Bluestone, J. A. The NOD mouse: a model of immune dysregulation. Annual review of immunology 23, 447\u2013485 (2005).","journal-title":"Annual review of immunology"},{"key":"60947_CR31","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1073\/pnas.74.6.2485","volume":"74","author":"AA Rossini","year":"1977","unstructured":"Rossini, A. A., Like, A. A., Chick, W. L., Appel, M. C. & Cahill, G. F. Jr. Studies of streptozotocin-induced insulitis and diabetes. Proceedings of the National Academy of Sciences of the United States of America 74, 2485\u20132489 (1977).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"60947_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF02573827","volume":"15","author":"MC Appel","year":"1978","unstructured":"Appel, M. C., Rossini, A. A., Williams, R. M. & Like, A. A. Viral studies in streptozotocin-induced pancreatic insulitis. Diabetologia 15, 327\u2013336 (1978).","journal-title":"Diabetologia"},{"key":"60947_CR33","doi-asserted-by":"crossref","unstructured":"Stull, N.D., Breite, A., McCarthy, R., Tersey, S.A. & Mirmira, R.G. Mouse islet of Langerhans isolation using a combination of purified collagenase and neutral protease. Journal of visualized experiments: JoVE (2012).","DOI":"10.3791\/4137"},{"key":"60947_CR34","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2337\/diab.43.6.827","volume":"43","author":"P Marchetti","year":"1994","unstructured":"Marchetti, P. et al. Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 43, 827\u2013830 (1994).","journal-title":"Diabetes"},{"key":"60947_CR35","doi-asserted-by":"crossref","unstructured":"Elizondo, D.M., et al. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB in vitro. Frontiers in immunology 10 (2019).","DOI":"10.3389\/fimmu.2019.00173"},{"key":"60947_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/imm.13010","volume":"156","author":"DM Elizondo","year":"2019","unstructured":"Elizondo, D. M., Andargie, T. E., Haddock, N. L., Boddie, T. A. & Lipscomb, M. W. Drebrin 1 in dendritic cells regulates phagocytosis and cell surface receptor expression through recycling for efficient antigen presentation. Immunology 156, 136\u2013146 (2019).","journal-title":"Immunology"},{"key":"60947_CR37","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3389\/fimmu.2017.01502","volume":"8","author":"DM Elizondo","year":"2017","unstructured":"Elizondo, D. M., Andargie, T. E., Yang, D., Kacsinta, A. D. & Lipscomb, M. W. Inhibition of Allograft Inflammatory Factor-1 in Dendritic Cells Restrains CD4(+) T Cell Effector Responses and Induces CD25(+)Foxp3(+) T Regulatory Subsets. Frontiers in immunology 8, 1502 (2017).","journal-title":"Frontiers in immunology"},{"key":"60947_CR38","doi-asserted-by":"crossref","unstructured":"Elizondo, D.M., et al. IL-10 producing CD8(+) CD122(+) PD-1(+) regulatory T cells are expanded by dendritic cells silenced for Allograft Inflammatory Factor-1. Journal of leukocyte biology (2018).","DOI":"10.1002\/JLB.1A0118-010RR"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60947-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60947-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60947-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T10:11:17Z","timestamp":1695895877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60947-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60947"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60947-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"9 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4362"}}